Advances in Cancer Immunotherapy™ Webinar - Clinical Updates from SITC 2019

When:  Feb 4, 2020 from 2:00 PM to 3:00 PM (ET)
aci17-sitc-clr.jpgOn February 4, 2020, join leading experts in cancer immunotherapy as they discuss the latest advances in cancer immunotherapy emerging from the Society for Immunotherapy of Cancer's 34th Annual Meeting & Pre-Conference Programs (SITC 2019). This is a FREE CME-, CNE-, CPE- and MOC- certified webinar intended for clinical oncologists, registered nurses, nurse practitioners, advanced practice registered nurses, pharmacists, physician assistants, emergency physicians, allied health professionals, other patient care providers, students and patient advocates.

Click here to register for this webinar.

Webinar Faculty

  • Sanjiv Agarwala, MD – Temple University
  • Igor Puzanov, MD – Roswell Park Comprehensive Cancer Center
  • Anil Shanker, PhD – Meharry Medical College

Webinar Agenda:
2:00–2:05 p.m. EST Overview: Welcome and Introductions
2:05–2:40 p.m. EST Presentation
2:40–2:55 p.m. EST Question and Answer Session
2:55–3:00 p.m. EST Closing Remarks

Continuing Education Credit Information:
Continuing Education Credits are available for physicians, nurses, and pharmacists. To view full accreditation information, click here.

Postgraduate Institute for MedicineSITC Logo

The 2019–2020 ACI series is jointly provided by Postgraduate Institute for Medicine and the Society for Immunotherapy of Cancer.

The 2019–2020 Advances in Cancer Immunotherapy™ educational series is supported, in part, by independent medical education grants from Amgen, AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb, Celgene Corporation, Exelixis, Inc., Genentech, Incyte Corporation and Merck & Co., Inc.